Epidemiology, genes and inflammatory bowel diseases in childhood

Digestive and Liver Disease

Volumn 40, Issue 1, 2008, Pages 3-11

  de Mesquita, M B ^a   Civitelli, F ^a   Levine, A ^b  

^a Sapienza   (Italy)

^b WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Child; Crohn's disease; Epidemiology; Ethnicity; Genes; IBD; Incidence; Ulcerative colitis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; DISC LARGE HOMOLOG 5 PROTEIN; GENE PRODUCT; HLA ANTIGEN; PROTEIN DLG5; PROTEIN IBD3; PROTEIN IBD5; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

CROHN DISEASE; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE CONTROL; DISEASE COURSE; ENTERITIS; ENVIRONMENTAL FACTOR; ETHNICITY; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GEOGRAPHIC DISTRIBUTION; HETEROZYGOTE; HUMAN; INCIDENCE; INNATE IMMUNITY; MUTATIONAL ANALYSIS; ONSET AGE; PATHOGENESIS; POPULATION RESEARCH; PREVALENCE; PROMOTER REGION; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; ULCERATIVE COLITIS;

CHILD; COLITIS, ULCERATIVE; CROHN DISEASE; DNA; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA ANTIGENS; HUMANS; INFLAMMATORY BOWEL DISEASES; MEMBRANE PROTEINS; MORBIDITY; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; TOLL-LIKE RECEPTOR 4; TUMOR SUPPRESSOR PROTEINS; WORLD HEALTH;

EID: 37049027755     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2007.07.165     Document Type: Short Survey

References (107)

1. Logan R.F. Inflammatory bowel disease incidence: up, down or unchanged?. Gut 42 (1998) 309-311
2. Russel M.G. Changes in the incidence of inflammatory bowel disease: what does it mean?. Eur J Intern Med 11 (2000) 191-196
3. Griffiths A.M. Specificities of inflammatory bowel disease in childhood. Best Pract Res Clin Gastroenterol 18 (2004) 509-523
4. Pappa H.M., Semrin G., Walker T.R., and Grand R.J. Pediatric inflammatory bowel disease. Curr Opin Gastroenterol 20 (2004) 333-340
5. Loftus Jr. E.V. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126 (2004) 1504-1517
6. Sawczenko A., and Sandhu B.K. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child 88 (2003) 995-1000
7. Heyman M.B., Kirschner B.S., Gold B.D., Ferry G., Baldassano R., Cohen S.A., et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr 146 (2005) 35-40
8. Babusukumar U., Wang T., McGuire E., Broeckel U., and Kugathasan S. Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease. Am J Gastroenterol 101 (2006) 1354-1361
9. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis-the Porto criteria. J Pediatr Gastroenterol Nutr 2005;41:1-7.
10. Ekbom A. The epidemiology of IBD: a lot of data but little knowledge. How shall we proceed?. Inflamm Bowel Dis 10 Suppl. 1 (2004) S32-S34
11. Barton J.R., Gillon S., and Ferguson A. Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983; marginal fall in ulcerative colitis, three-fold rise in Crohn's disease. Gut 30 (1989) 618-622
12. Sawczenko A., Sandhu B.K., Logan R.F., Jenkins H., Taylor C.J., Mian S., et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 357 (2001) 1093-1094
13. Hassan K., Cowan F.J., and Jenkins H.R. The incidence of childhood inflammatory bowel disease in Wales. Eur J Pediatr 159 (2000) 261-263
14. Auvin S., Molinie F., Gower-Rousseau C., Brazier F., Merle V., Grandbastien B., et al. Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999). J Pediatr Gastroenterol Nutr 41 (2005) 49-55
15. Tourtelier Y., Dabadie A., Tron I., Alexandre J.L., Robaskiewicz M., Cruchant E., et al. [Incidence of inflammatory bowel disease in children in Brittany (1994-1997) Breton association of study and research on digestive system diseases (Abermad)]. Arch Pediatr 7 (2000) 377-384
16. Olafsdottir E.J., Fluge G., and Haug K. Chronic inflammatory bowel disease in children in western Norway. J Pediatr Gastroenterol Nutr 8 (1989) 454-458
17. Lindberg E., Lindquist B., Holmquist L., and Hildebrand H. Inflammatory bowel disease in children and adolescents in Sweden, 1984-1995. J Pediatr Gastroenterol Nutr 30 (2000) 259-264
18. Kugathasan S., Judd R.H., Hoffmann R.G., Heikenen J., Telega G., Khan F., et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr 143 (2003) 525-531
19. Russel M.G., and Stockbrugger R.W. Epidemiology of inflammatory bowel disease: an update. Scand J Gastroenterol 31 (1996) 417-427
20. Armitage E., Drummond H.E., Wilson D.C., and Ghosh S. Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland. Eur J Gastroenterol Hepatol 13 (2001) 1439-1447
21. van der Zaag-Loonen H.J., Casparie M., Taminiau J.A., Escher J.C., Pereira R.R., and Derkx H.H. The incidence of pediatric inflammatory bowel disease in the Netherlands: 1999-2001. J Pediatr Gastroenterol Nutr 38 (2004) 302-307
22. Bjornsson S., and Johannsson J.H. Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide, epidemiological study. Eur J Gastroenterol Hepatol 12 (2000) 31-38
23. Ravikumara M., and Sandhu B.K. Epidemiology of inflammatory bowel diseases in childhood. Indian J Pediatr 73 (2006) 717-721
24. Pozler O., Maly J., Bonova O., Dedek P., Fruhauf P., Havlickova A., et al. Incidence of Crohn disease in the Czech Republic in the years 1990 to 2001 and assessment of pediatric population with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 42 (2006) 186-189
25. Phavichitr N., Cameron D.J., and Catto-Smith A.G. Increasing incidence of Crohn's disease in Victorian children. J Gastroenterol Hepatol 18 (2003) 329-332
26. Higashi A., Watanabe Y., Ozasa K., Hayashi K., Aoike A., and Kawai K. Prevalence and mortality of ulcerative colitis and Crohn's disease in Japan. Gastroenterol Jpn 23 (1988) 521-526
27. Tsai C.H., Chen H.L., Ni Y.H., Hsu H.Y., Jeng Y.M., Chang C.J., et al. Characteristics and trends in incidence of inflammatory bowel disease in Taiwanese children. J Formos Med Assoc 103 (2004) 685-691
28. Sung J.J., Hsu R.K., Chan F.K., Liew C.T., Lau J.W., and Li A.K. Crohn's disease in the Chinese population. An experience from Hong Kong. Dis Colon Rectum 37 (1994) 1307-1309
29. Lee Y.M., Fock K., See S.J., Ng T.M., Khor C., and Teo E.K. Racial differences in the prevalence of ulcerative colitis and Crohn's disease in Singapore. J Gastroenterol Hepatol 15 (2000) 622-625
30. Jiang L., Xia B., Li J., Ye M., Yan W., Deng C., et al. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis 12 (2006) 212-217
31. Sood A., Midha V., Sood N., Bhatia A.S., and Avasthi G. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 52 (2003) 1587-1590
32. Ouyang Q., Tandon R., Goh K.L., Ooi C.J., Ogata H., and Fiocchi C. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol 21 (2005) 408-413
33. Wright J.P., Marks I.N., Jameson C., Garisch J.A., Burns D.G., and Kottler R.E. Inflammatory bowel disease in Cape Town, 1975-1980. Part I. Ulcerative colitis. S Afr Med J 63 (1983) 223-226
34. Wright J.P., Marks I.N., Jameson C., Garisch J.A., and Burns D.G. Kottler RE: Inflammatory bowel disease in Cape Town, 1975-1980. Part II. Crohn's disease. S Afr Med J 63 (1983) 226-229
35. Sandler R.S., and Golden A.L. Epidemiology of Crohn's Disease. J Clin Gastroenterol 8 (1986) 160-165
36. Ling K.L., Ooi C.J., Luman W., Cheong W.K., Choen F.S., and Ng H.S. Clinical characteristics of ulcerative colitis in Singapore, a multiracial city-state. J Clin Gastroenterol 35 (2002) 144-148
37. Loftus Jr. E.V., and Sandborn W.J. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 31 (2002) 1-20
38. Karban A., Itay M., Davidovich O., Leshinsky-Silver E., Kimmel G., Fidder H., et al. Risk factors for perianal Crohn's disease: the role of genotype, phenotype, and ethnicity. Am J Gastroenterol. 102 (2007) 1702-1708
39. Montgomery S.M., Morris D.L., Pounder R.E., and Wakefield A.J. Asian ethnic origin and the risk of inflammatory bowel disease. Eur J Gastroenterol Hepatol 11 (1999) 543-546
40. Basu D., Lopez I., Kulkarni A., and Sellin J.H. Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol 100 (2005) 2254-2261
41. Armitage E., Drummond H., Ghosh S., and Ferguson A. Incidence of juvenile-onset Crohn's disease in Scotland. Lancet 353 (1999) 1496-1497
42. Shivananda S., Lennard-Jones J., Logan R., Fear N., Price A., and Carpenter L.M. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39 (1996) 690-697
43. Montgomery S.M., Pounder R.E., and Wakefield A.J. Infant mortality and the incidence of inflammatory bowel disease. Lancet 349 (1997) 472-473
44. Gilat T., Hacohen D., Lilos P., and Langman M.J. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand J Gastroenterol 22 (1987) 1009-1024
45. Hildebrand H., Finkel Y., Grahnquist L., Lindholm J., Ekbom A., and Askling J. Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001. Gut 52 (2003) 1432-1434
46. Sorensen H.T., Pedersen L., Norgard B., Fonager K., and Rothman K.J. Does month of birth affect risk of Crohn's disease in childhood and adolescence?. Br Med J 323 (2001) 907
47. Ruemmele F.M., El Khoury M.G., Talbotec C., Maurage C., Mougenot J.F., Schmitz J., et al. Characteristics of inflammatory bowel disease with onset during the first year of life. J Pediatr Gastroenterol Nutr 43 (2006) 603-609
48. Gryboski J.D. Crohn's disease in children 10 years old and younger: comparison with ulcerative colitis. J Pediatr Gastroenterol Nutr 18 (1994) 174-182
49. Marx G., Seidman E.G., Martin S.R., and Deslandres C. Outcome of Crohn's disease diagnosed before two years of age. J Pediatr 140 (2002) 470-473
50. Mamula P., Telega G.W., Markowitz J.E., Brown K.A., Russo P.A., Piccoli D.A., et al. Inflammatory bowel disease in children 5 years of age and younger. Am J Gastroenterol 97 (2002) 2005-2010
51. Baron S., Turck D., Leplat C., Merle V., Gower-Rousseau C., Marti R., et al. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut 54 (2005) 357-363
52. Levine A, Kugathasan S, Annese V, Biank V, Leshinsky-Silver E, Davidovich O, et al. Pediatric onset Crohn's colitis is characterized by genotype-dependent age-related susceptibility. Inflamm Bowel Dis. 2007 Aug 30; [Epub ahead of print].
53. Polito II J.M., Childs B., Mellits E.D., Tokayer A.Z., Harris M.L., and Bayless T.M. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 111 (1996) 580-586
54. Montgomery S.M., and Ekbom A. Epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol 18 (2002) 416-420
55. Dalziel T.K. Thomas Kennedy Dalziel 1861-1924. Chronic interstitial enteritis. Dis Colon Rectum 32 (1989) 1076-1078
56. Whorwell P.J., Holdstock G., Whorwell G.M., and Wright R. Bottle feeding, early gastroenteritis, and inflammatory bowel disease. Br Med J 1 (1979) 382
57. Gent A.E., Hellier M.D., Grace R.H., Swarbrick E.T., and Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 343 (1994) 766-767
58. Ekbom A. Appendicectomy and childhood hygiene: different sides of the same coin?. Gut 43 (1998) 451
59. Lashner B.A., and Loftus Jr. E.V. True or false? The hygiene hypothesis for Crohn's disease. Am J Gastroenterol 101 (2006) 1003-1004
60. Amre D.K., Lambrette P., Law L., Krupoves A., Chotard V., Costea F., et al. Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn's disease: a case-control study. Am J Gastroenterol 101 (2006) 1005-1011
61. Bernstein C.N., Rawsthorne P., Cheang M., and Blanchard J.F. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol 101 (2006) 993-1002
62. García Rodríguez L.A., Ruigómez A., and Panés J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 130 (2006) 1588-1594
63. Haslam N., Mayberry J.F., Hawthorne A.B., Newcombe R.G., Holmes G.K., and Probert C.S. Measles, month of birth, and Crohn's disease. Gut 47 (2000) 801-803
64. Gaya D.R., Russell R.K., Nimmo E.R., and Satsangi J. New genes in inflammatory bowel disease: lessons for complex diseases?. Lancet 367 (2006) 1271-1284
65. Tysk C., Lindberg E., Jarnerot G., and Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29 (1988) 990-996
66. Orholm M., Binder V., Sorensen T.I., Rasmussen L.P., and Kyvik K.O. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol 35 (2000) 1075-1081
67. Thompson N.P., Driscoll R., Pounder R.E., and Wakefield A.J. Genetics versus environment in inflammatory bowel disease: results of a British twin study. Br Med J 312 (1996) 95-96
68. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
69. Hampe J., Cuthbert A., Croucher P.J., Mirza M.M., Mascheretti S., Fisher S., et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357 (2001) 1925-1928
70. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
71. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278 (2003) 8869-8872
72. Arnott I.D., Nimmo E.R., Drummond H.E., Fennell J., Smith B.R., MacKinlay E., et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?. Genes Immun 5 (2004) 417-425
73. Idestrom M., Rubio C., Granath F., Finkel Y., and Hugot J.P. CARD15 mutations are rare in Swedish pediatric Crohn disease. J Pediatr Gastroenterol Nutr 40 (2005) 456-460
74. Cuthbert A.P., Fisher S.A., Mirza M.M., King K., Hampe J., Croucher P.J., et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 122 (2002) 867-874
75. Economou M., Trikalinos T.A., Loizou K.T., Tsianos E.V., and Ioannidis J.P. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 99 (2004) 2393-2404
76. Ahmad T., Armuzzi A., Bunce M., Mulcahy-Hawes K., Marshall S.E., Orchard T.R., et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 122 (2002) 854-866
77. Lesage S., Zouali H., Cezard J.P., Colombel J.F., Belaiche J., Almer S., et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70 (2002) 845-857
78. Brant S.R., Picco M.F., Achkar J.P., Bayless T.M., Kane S.V., Brzezinski A., et al. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis 9 (2003) 281-289
79. Hampe J., Grebe J., Nikolaus S., Solberg C., Croucher P.J., Mascheretti S., et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 359 (2002) 1661-1665
80. Brandt L.J., and Dickstein G. Inflammatory bowel disease: specific concerns in the elderly. Geriatrics 44 (1989) 107-111
81. Watanabe T., Kitani A., Murray P.J., and Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 5 (2004) 800-808
82. Kobayashi K.S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., Nunez G., et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307 (2005) 731-734
83. Maeda S., Hsu L.C., Liu H., Bankston L.A., Iimura M., Kagnoff M.F., et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307 (2005) 734-738
84. Netea M.G., Kullberg B.J., de Jong D.J., Franke B., Sprong T., Naber T.H., et al. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Eur J Immunol 34 (2004) 2052-2059
85. Watanabe T., Kitani A., and Strober W. NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn's disease. Gut 54 (2005) 1515-1518
86. Hommes D.W., and van Deventer S.J. Endoscopy in inflammatory bowel diseases. Gastroenterology 126 (2004) 1561-1573
87. Russell R.K., Drummond H.E., Nimmo E.E., Anderson N., Smith L., Wilson D.C., et al. Genotype-phenotype analysis in childhood-onset Crohn's disease: NOD2/CARD15 variants consistently predict phenotypic characteristics of severe disease. Inflamm Bowel Dis 11 (2005) 955-964
88. Ferraris A., Torres B., Knafelz D., Barabino A., Lionetti P., de Angelis G.L., et al. Relationship between CARD15, SLC22A4/5, and DLG5 polymorphisms and early-onset inflammatory bowel diseases: an Italian multicentric study. Inflamm Bowel Dis 12 (2006) 355-361
89. Leshinsky-Silver E., Karban A., Buzhakor E., Fridlander M., Yakir B., Eliakim R., et al. Is age of onset of Crohn's disease governed by mutations in NOD2/caspase recruitment domains 15 and Toll-like receptor 4? Evaluation of a pediatric cohort. Pediatr Res 58 (2005) 499-504
90. Annese V., Palmieri O., Latiano A., Ardizzone S., Castiglione F., Cottone M., et al. Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study. Dig Liver Dis 36 (2004) 121-124
91. Kugathasan S., Loizides A., Babusukumar U., McGuire E., Wang T., Hooper P., et al. Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and White children with Crohn's disease. Inflamm Bowel Dis 11 (2005) 631-638
92. Weiss B., Shamir R., Bujanover Y., Waterman M., Hartman C., Fradkin A., et al. NOD2/CARD15 mutation analysis and genotype-phenotype correlation in Jewish pediatric patients compared with adults with Crohn's disease. J Pediatr 145 (2004) 208-212
93. Levine A., Karban A., Eliakim R., Shaoul R., Reif S., Pacht A., et al. A polymorphism in the TNF-alpha promoter gene is associated with pediatric onset and colonic location of Crohn's disease. Am J Gastroenterol 100 (2005) 407-413
94. Rioux J.D., Daly M.J., Silverberg M.S., Lindblad K., Steinhart H., Cohen Z., et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 29 (2001) 223-228
95. Goldstein D.B. Islands of linkage disequilibrium. Nat Genet 29 (2001) 109-111
96. Noble C.L., Nimmo E.R., Drummond H., Ho G.T., Tenesa A., Smith L., et al. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology 129 (2005) 1854-1864
97. Peltekova V.D., Wintle R.F., Rubin L.A., Amos C.I., Huang Q., Gu X., et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36 (2004) 471-475
98. Torok H.P., Glas J., Tonenchi L., Lohse P., Muller-Myhsok B., Limbersky O., et al. Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut 54 (2005) 1421-1427
99. Vermeire S., Pierik M., Hlavaty T., Claessens G., van Schuerbeeck N., Joossens S., et al. Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD. Gastroenterology 129 (2005) 1845-1853
100. Russell R.K., Drummond H.E., Nimmo E.R., Anderson N.H., Noble C.L., Wilson D.C., et al. Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease. Gut 55 (2006) 1114-1123
101. Franchimont D., Vermeire S., El Housni H., Pierik M., Van Steen K., Gustot T., et al. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53 (2004) 987-992
102. Ouburg S., Mallant-Hent R., Crusius J.B., van Bodegraven A.A., Mulder C.J., Linskens R., et al. The toll-like receptor 4 (TLR4) Asp299Gly polymorphism is associated with colonic localisation of Crohn's disease without a major role for the Saccharomyces cerevisiae mannan-LBP-CD14-TLR4 pathway. Gut 54 (2005) 439-440
103. Friedrichs F., Brescianini S., Annese V., Latiano A., Berger K., Kugathasan S., et al. Evidence of transmission ratio distortion of DLG5 R30Q variant in general and implication of an association with Crohn disease in men. Hum Genet 119 (2006) 305-311
104. Biank V., Friedrichs F., Babusukumar U., Wang T., Stoll M., Broeckel U., et al. DLG5 R30Q variant is a female-specific protective factor in pediatric onset Crohn's disease. Am J Gastroenterol 102 (2007) 391-398
105. Trachtenberg E.A., Yang H., Hayes E., Vinson M., Lin C., Targan S.R., et al. HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish caucasian populations. Hum Immunol 61 (2000) 326-333
106. Silverberg M.S., Mirea L., Bull S.B., Murphy J.E., Steinhart A.H., Greenberg G.R., et al. A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease. Inflamm Bowel Dis 9 (2003) 1-9
107. Levine A., Karban A., Dalal I., Eliakim R., Tzofi T., Boaz M., et al. Evaluation of the R 381Q variant of IL23 receptor in pediatric and adult onset Crohn's disease. J Pediatr Gastroenterol Nutr 44 (2007) e112